Biosciences
-
Biologics
Kuros closes acquisition of Xpand creating a leading commercial-stage orthobiologics company
25 Jan 17 Kuros Biosciences (SIX:KURN) today announced the closing of the all-share strategic acquisition of Xpand Biotechnology B.V. of…
Read More » -
Biologics
Celling Biosciences Opens International Office in Brazil
AUSTIN, Texas, Aug. 22, 2016 /PRNewswire/ — Celling Biosciences, the foremost pioneer in point-of-care cell therapies, is opening an international office…
Read More »